Skip to main content
. 2023 Dec 12;86(1):128–134. doi: 10.1292/jvms.23-0463

Table 1. Neutralization titers against 18 pseudotyped virus.

Rabbit antiserum Phylogroup Neutralization titers against VSVp (IC75)
I
II
Unclassified
RABV GBLV ABLV KHUV BBLV EBLV-2 ARAV KBLV EBLV-1 DUVV IRKV TWBLV MOKV SHIBV LBV WCBV LLEBV IKOV
RABV-G I 2,187 726 2,475 444 951 1,348 468 450 89 1,211 1,989 135 <10 <10 <10 <10 <10 <10
GBLV-G I 10,399 23,970 40,105 11,897 22,308 4,739 5,312 7,632 874 20 3,662 8,174 49 520 30 213 <10 <10
ABLV-G I 7,671 37,844 81,190 19,883 12,229 8,733 7,664 9,583 2,229 7,026 10,193 456 760 792 470 <10 <10 <10
KHUV-G I 487 3,985 9,228 11,342 1,954 1,455 1,931 3,501 155 51 443 166 352 937 228 <10 <10 <10
BBLV-G I 4,489 24,544 37,041 16,180 32,422 11,573 11,660 12,695 3,026 15,360 11,753 7,289 93 191 330 <10 <10 <10
EBLV-2-G I 1,743 12,916 34,401 9,532 9,250 13,190 10,699 6,968 5,588 1,402 3,263 749 272 1,264 294 38 <10 <10
ARAV-G I 5,052 9,050 16,112 5,086 6,592 3,763 15,416 4,985 2,014 4,187 9,732 5,531 <10 26 14 <10 <10 <10
KBLV-G I 1,082 4,902 16,737 3,787 2,358 3,208 1,518 8,643 370 777 421 1,169 <10 <10 12 <10 <10 <10
EBLV-1-G I 970 2,524 5,805 4,365 3,410 3,088 2,266 3,563 4,012 2,145 5,894 1,191 688 950 412 27 <10 <10
DUVV-G I 4,880 19,159 59,446 38,658 29,820 47,743 37,519 35,864 17,659 116,600 60,585 2,325 43 353 164 <10 <10 <10
IRKV-G I 1,363 1,288 2,705 1,559 1,278 1,338 733 1,149 620 1,583 7,878 756 53 10 167 <10 <10 <10
TWBLV-G I 5,886 14,278 20,533 5,981 10,028 6,499 5,640 9,130 1,821 5,301 6,321 44,684 104 92 87 <10 <10 <10

MOKV-G II 956 959 7,125 3,146 570 1,592 529 1,657 30 32 74 299 201,967 4,311 2,924 67 <10 24
SHIBV-G II 14,254 43,130 64,102 43,625 12,745 3,711 9,606 10,610 888 604 11,297 911 36,372 512,586 73,811 <10 <10 <10
LBV-G II 166 553 1,491 278 223 123 33 272 20 29 195 63 154 4,697 5,103 <10 <10 42

WCBV-G Unclassified 148 1,559 3,716 2,067 2,437 2,910 86 617 359 40 177 48 70 45 138 8,116 <10 45
LLEBV-G Unclassified <10 <10 <10 23 56 295 <10 <10 <10 <10 <10 <10 <10 <10 <10 <10 39,418 2,867
IKOV-G Unclassified <10 <10 <10 <10 <10 31 <10 <10 <10 <10 <10 <10 <10 327 12 <10 17 22,752

Rabipur-1 I (vaccine) 21,066 22,289 36,116 10,046 23,967 15,403 14,030 11,803 5,624 16,880 31,772 8,860 <10 78 17 <10 <10 <10
Rabipur-2 I (vaccine) 7,887 11,055 20,947 3,193 7,848 8,059 5,446 4,386 2,067 8,791 11,494 2,120 44 158 72 <10 <10 <10
KMB-1 I (vaccine) 19,532 13,531 18,577 7,089 17,253 10,750 7,458 7,471 2,578 16,155 11,008 7,247 <10 <10 <10 <10 <10 <10
KMB-2 I (vaccine) 9,004 3,295 7,359 2,143 2,821 1,854 1,052 766 146 1,223 1,456 1,965 <10 <10 <10 <10 <10 <10

The abbreviations for the 18 pseudotyped viruses (VSVp) and antisera against each lyssavirus glycoprotein (-G) are listed below: RABV, Rabies lyssavirus; GBLV, Gannoruwa bat lyssavirus; ABLV, Australian bat lyssavirus; KHUV, Khujand lyssavirus; BBLV, Bokeloh bat lyssavirus; EBLV-2, European bat lyssavirus 2; ARAV, Aravan lyssavirus; KBLV, Kotalahti bat lyssavirus; EBLV-1, European bat lyssavirus 1; DUVV, Duvenhage lyssavirus; IRKV, Irkut lyssavirus; TWBLV, Taiwan bat lyssavirus; MOKV, Mokola lyssavirus; SHIBV, Shimoni bat lyssavirus; LBV, Lagos bat lyssavirus; WCBV, West Caucasian bat lyssavirus; LLEBV, Lleida bat lyssavirus; IKOV, Ikoma lyssavirus. The sera of the rabbits immunized with human rabies vaccine (Rabipur) and animal rabies vaccine (KMB) were also used.